Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Exercise and sex education program tested in people with endometriosis

Tests exercise plus sex education in adults aged 18 to 50 with endometriosis.

Plain-language title generated from the registry record
Registry title: Effect of a Therapeutic Exercise and an Education Program on Sexual Function and Experience in People With Endometriosis

Key facts

Where
Valencia, SpainSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

Source: NCT06810297, who can take part

Where in Spain

  • Laura Fuentes AparicioValencia, SpainNo longer taking part
  • University of ValenciaValencia, SpainNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Valencia
Trial code
NCT06810297
Record updated
18 May 2026
Original description
This is a randomized clinical trial that will be carried out in people with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic exercise combine with sexual education, and the control group (CG) who will receive the therapeutic exercise program.Read full original descriptionShow less

Effect of a Therapeutic Exercise and an Education Program on Sexual Function and Experience in People With Endometriosis

This is a randomized clinical trial that will be carried out in people with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic exercise combine with sexual education, and the control group (CG) who will receive the therapeutic exercise program.

The participants will be evaluated at three moments: before starting the study (T1), after the 8-week treatment program (T2) and after 4 weeks of follow-up in which they will be encouraged to continue with the treatment (T3). Objective and subjective data of the participants will be evaluated. T1 will be assessed with a sociodemographic questionnaire and the FSFI and MSSCQ surveys. T2 and T3 will assess blood pressure, heart rate, variability of the autonomic system, the ability to dissociate the lumbopelvic movement from the thoracolumbar, measurement of the muscles of the transverse, internal and external obliques, the distance between the rectus abdominis and the pelvic floor, subjective perception of effort during exercise and subjective perception of orgasmic intensity.

Inclusion: People of legal age (over 18 years old); Not older than 50 years old; Currently residing in Spain; Spanish speakers; With a medical diagnosis of endometriosis; Without any other associated gynecological pathology.

Exclusion: People over 50 years old; Minors; Those with cognitive limitations that prevent them from completing the different questionnaires used; People who are involved in litigation processes; People with gynecological pathologies other than endometriosis.

ClinicalTrials.gov NCT06810297